跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Exendin-3
首页
药物
Exendin-3
Exendin-3
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Analogues of exendin-4 and exendin-3
申请人: IPSEN PHARMA SAS
优先权: 2007
EP
US
2 件公开
Exendin polypeptide linked to biotin, method for the preparation thereof and pharmaceutical composition comprising the same
申请人: LEE KANG CHOON
优先权: 2008
US
2 件公开
Long-acting exendins and exendin agonists
申请人: YEDA RES & DEV
优先权: 2003
US
Exendin-4 derivative and solid phase chemical synthesis thereof
申请人: UNIV EAST CHINA NORMAL
优先权: 2009
CN
Long-acting Exendin-9-39, application of long-acting Exendin-9-39 in hypoglycemia treatment and medicine for treating hypoglycemia
申请人: NANJING ASCENDREAL MEDICAL TECH CO LTD
优先权: 2022
CN
Novel process for preparing recombinant Exendin-4 polypeptide
申请人: DONGGUAN BAOLIJIAN BIOENGINEER
优先权: 2004
CN
Peptide derivatives of exendin-4
申请人: GOTTHARDT MARTIN
优先权: 2004
CN
US
5 件公开
A recombinant fusion protein having hypoglycemic activity and transdermal capability, a coding gene and applications of the recombinant fusion protein
申请人: UNIV CHINA PHARMA
优先权: 2016
CN
药物
反馈